Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 14, 2027; 33(2): 125044
Published online Jan 14, 2027. doi: 10.3748/wjg.125044
Published online Jan 14, 2027. doi: 10.3748/wjg.125044
Table 1 Liver, body weight, and diet intake by mouse group, mean ± SEM
| Mouse group | Chow (n = 8) | DDC (n = 9) | Lauric acid (n = 6) | DDC/Lauric acid (n = 6) |
| Initial body weight (g) | 23 ± 0.37 | 23.67 ± 0.55 | 24.00 ± 0.36 | 25.83 ± 0.95c |
| Final body weight (g) | 25.13 ± 0.91b | 17.99 ± 0.50 | 24.37 ± 0.49b | 17.73 ± 0.68 |
| Liver weight (g) | 1.24 ± 0.07b | 0.95 ± 0.01 | 1.15 ± 0.05b | 0.88 ± 0.05 |
| Liver weight/final body weight ratio | 0.04 ± 0.001 | 0.05 ± 0.001 | 0.05 ± 0.002 | 0.05 ± 0.001 |
| Diet intake (g/day/mouse) | 4.47 ± 0.2a | 2.94 ± 0.43 | 2.85 ± 0.05 | 2.65 ± 0.29 |
- Citation: Ghosh S, Devereaux MW, Anderson CC, Orlicky DJ, Sokol RJ. Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression. World J Gastroenterol 2027; 33(2): 125044
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/125044.htm
- DOI: https://dx.doi.org/10.3748/wjg.125044